103 related articles for article (PubMed ID: 9496913)
1. Characterization of rare p53 mutants from carcinogen-treated albumin-simian virus 40 T-antigen transgenic rats.
Haas MJ; Pitot HC
Mol Carcinog; 1998 Feb; 21(2):128-34. PubMed ID: 9496913
[TBL] [Abstract][Full Text] [Related]
2. Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations.
Kubicka S; Trautwein C; Niehof M; Manns M
Hepatology; 1997 Apr; 25(4):867-73. PubMed ID: 9096590
[TBL] [Abstract][Full Text] [Related]
3. p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells.
Puisieux A; Ponchel F; Ozturk M
Oncogene; 1993 Feb; 8(2):487-90. PubMed ID: 8381223
[TBL] [Abstract][Full Text] [Related]
4. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations in bladder carcinoma cell lines.
Cooper MJ; Haluschak JJ; Johnson D; Schwartz S; Morrison LJ; Lippa M; Hatzivassiliou G; Tan J
Oncol Res; 1994; 6(12):569-79. PubMed ID: 7787250
[TBL] [Abstract][Full Text] [Related]
6. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
[TBL] [Abstract][Full Text] [Related]
7. The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in mice.
Bennoun M; Grimber G; Couton D; Seye A; Molina T; Briand P; Joulin V
Oncogene; 1998 Sep; 17(10):1253-9. PubMed ID: 9771968
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen.
Catalano A; Romano M; Martinotti S; Procopio A
Oncogene; 2002 Apr; 21(18):2896-900. PubMed ID: 11973650
[TBL] [Abstract][Full Text] [Related]
10. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
11. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
[TBL] [Abstract][Full Text] [Related]
12. p53 transactivation domain mutant Q22, S23 is impaired for repression of promoters and mediation of apoptosis.
Roemer K; Mueller-Lantzsch N
Oncogene; 1996 May; 12(10):2069-79. PubMed ID: 8668332
[TBL] [Abstract][Full Text] [Related]
13. Identification of SV40 T-antigen mutants that alter T-antigen-induced chromosome damage in human fibroblasts.
Ray FA; Waltman MJ; Lehman JM; Little JB; Nickoloff JA; Kraemer PM
Cytometry; 1998 Apr; 31(4):242-50. PubMed ID: 9551599
[TBL] [Abstract][Full Text] [Related]
14. p53 mutants with changes in conserved region II: three classes with differing antibody reactivity, SV40 T antigen binding and ability to inhibit transformation of rat cells.
Schmieg FI; Simmons DT
Oncogene; 1993 Aug; 8(8):2043-50. PubMed ID: 8393158
[TBL] [Abstract][Full Text] [Related]
15. Functional abrogation of p53 is required for T-Ag induced proliferation in cardiomyocytes.
Huh NE; Pasumarthi KB; Soonpaa MH; Jing S; Patton B; Field LJ
J Mol Cell Cardiol; 2001 Aug; 33(8):1405-19. PubMed ID: 11448130
[TBL] [Abstract][Full Text] [Related]
16. An unexpected role for p53 in augmenting SV40 large T antigen-mediated tumorigenesis.
Herzig M; Novatchkova M; Christofori G
Biol Chem; 1999 Feb; 380(2):203-11. PubMed ID: 10195427
[TBL] [Abstract][Full Text] [Related]
17. Wild-type p53 activates transcription in vitro.
Farmer G; Bargonetti J; Zhu H; Friedman P; Prywes R; Prives C
Nature; 1992 Jul; 358(6381):83-6. PubMed ID: 1614538
[TBL] [Abstract][Full Text] [Related]
18. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells].
Kremenetskaia OS; Logacheva NP; Baryshnikov AIu; Chumakov PM; Kopnin BP
Tsitologiia; 1996; 38(12):1280-93. PubMed ID: 9163103
[TBL] [Abstract][Full Text] [Related]
19. Binding of cellular proteins to a conformational domain of tumor suppressor protein p53.
Maxwell SA; Roth JA
Oncogene; 1993 Dec; 8(12):3421-6. PubMed ID: 8247546
[TBL] [Abstract][Full Text] [Related]
20. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice.
Gordon J; Del Valle L; Otte J; Khalili K
Oncogene; 2000 Oct; 19(42):4840-6. PubMed ID: 11039901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
